Influence of cytochrome P450 CYP2C9 genotypes in lung cancer risk

Cancer Letters

Volumn 180, Issue 1, 2002, Pages 41-46

  García Martín, Elena ^a   Martínez, Carmen ^a   Ladero, José M ^b   Gamito, F J ^c   Rodriguez Lescure, Alvaro ^b   Agúndez, José A G ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c Hospital Insalud   (Spain)

Author keywords

CYP2C9; Genotype; Lung cancer; Metabolism

Indexed keywords

CYTOCHROME P450 2C9;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

ALLELES; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES;

EID: 0037030578     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00015-0     Document Type: Article

References (19)

1. Biochemistry and molecular biology of the human CYP2C subfamily
2. Relationship between CYP2C9 and CYP2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4′-hydroxylation activities in livers of Japanese and Caucasian populations
3. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with the NADPH:cytochrome P450 oxidoreductase
4. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism
5. Genetic analysis of the human cytochrome P450 CYP2C9 locus
6. Lung cancer in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County
7. Validation of methods for CYP2C9 genotyping: Frequencies of mutant alleles in a Swedish population
8. High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population
9. Allelic variants of the human cytochrome P450 2C9: Baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms
10. Cancer in the European community and its member states
11. Confidence intervals
12. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs
13. Selection and characterization of human cytochrome P450 1B1 mutants by random mutagenesis
14. Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: Evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes
15. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450
16. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene
17. Contribution of human cytochrome P450 to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast
18. Analyzes of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases
19. CYP2C9 mutant alleles in a rural U.S. Caucasian population